Table 2.
Distribution of subtypes and HAART regimen exposure across the 48 HIV-1 genome sequences analyzed.
| Patient | Subtype/URF | HAART Regimen | Patient | Subtype/URF | HAART Regimen |
|---|---|---|---|---|---|
| 1-HI | B | AZT+3TC+NVP | 31-HI | B | TDF+3TC+EFV |
| 2-HI# | B | AZT+3TC+EFV | 32-HI | BF | TDF+3TC+EFV |
| 3-HI | B | TDF+3TC+EFV | 2-HU-UFRJ | B | TDF+3TC+EFV |
| 4-HI | B | TDF+3TC+EFV | 3-HU-UFRJ | B | AZT+3TC+EFV |
| 5-HI | B | AZT+3TC+ATV | 4-HU-UFRJ | B | AZT+3TC+EFV |
| 6-HI | F1 | AZT+3TC+ATV/r | 6-HU-UFRJ | B | AZT+3TC+EFV |
| 8-HI | BC | TDF+3TC+EFV | 7-HU-UFRJ | B | AZT+3TC+EFV |
| 11-HI | BF | TDF+3TC+EFV | 9-HU-UFRJ | F1 | AZT+3TC+AZT/r |
| 12-HI | B | TDF+3TC+EFV | 10-HU-UFRJ | B | TDF+3TC+EFV |
| 13-HI | B | TDF+3TC+EFV | 12-HU-UFRJ | B | TDF+3TC+EFV |
| 14-HI | B | AZT+3TC+LPV/r | 1-HU-FURG | C | TDF+3TC+EFV |
| 15-HI | B | TDF+3TC+EFV | 2-HU-FURG | C | TDF+3TC+EFV |
| 16-HI | B | AZT+3TC+FPV/r | 3-HU-FURG | BC | AZT+3TC+EFV |
| 17-HI | BF1 | AZT+3TC+ATV/r | 6-HU-FURG | C | TDF+3TC+AZT/r |
| 18-HI | B | TDF+3TC+EFV | 7-HU-FURG | C | TDF+3TC+DRV/r |
| 19-HI | B | AZT+3TC+EFV | 8-HU-FURG | C | TDF+3TC+ATV |
| 20-HI | B | TDF+3TC+EFV | 10-HU-FURG | C | TDF+3TC+EFV |
| 21-HI | B | TDF+EFV+FTC | 12-HU-FURG | C | TDF+3TC+EFV |
| 22-HI | B | TDF+3TC+EFV | 13-HU-FURG | C | TDF+3TC+EFV |
| 23-HI | B | TDF+3TC+EFV | 14-HU-FURG | BF1 | AZT+3TC+AZT/r |
| 26-HI | B | TDF+3TC+EFV | 16-HU-FURG | C | TDF+3TC+EFV |
| 27-HI | B | TDF+3TC+EFV | 17-HU-FURG | C | AZT+3TC+LPV/r |
| 28-HI | BF | TDF+3TC+EFV | 18-HU-FURG | BF1 | TDF+3TC+EFV |
| 29-HI | B | TDF+3TC+EFV | 20-HU-FURG | BC | TDF+3TC+EFV |
#The near full-length genomes are represented in bold.